The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis

Tara M. Mackay; F. Jasmijn Smits; Daphne Roos; Bert A. Bonsing; Koop Bosscha; Olivier R. Busch; Geert-Jan Creemers; Ronald M. van Dam; Casper H.J. van Eijck; Michael F. Gerhards; Hanneke W. M. van Laarhoven; Marc G. Besselink

doi:https://doi.org/10.1016/j.hpb.2019.06.019

doi.org/10.1016/j.hpb.2019.06.019

The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis

,

,

..., Marc G. Besselink

81

HPB2.90

Volume: 22, Issue: 2, Pages: 233 - 240

Published: Feb 1, 2020

Abstract

BackgroundThe relation between type of postoperative complication and not receiving chemotherapy after resection of pancreatic ductal adenocarcinoma (PDAC) is unclear. The aim was to investigate which patient factors and postoperative complications were associated with not receiving adjuvant chemotherapy.MethodsPatients who underwent resection (2014–2017) for PDAC were identified from the nationwide mandatory Dutch Pancreatic Cancer Audit. The...

Paper Fields

Paper Details

Title

The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis

DOI

doi.org/10.1016/j.hpb.2019.06.019

Published Date

Feb 1, 2020

Journal

HPB

Volume

22

Issue

2

Pages

233 - 240

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History